These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15065522)

  • 1. [Secretolytic therapy of acid-dependent diseases of the digestive system from the point of view of a clinician].
    Grinevich VB; Uspenskiĭ IuP
    Eksp Klin Gastroenterol; 2003; (6):16-8. PubMed ID: 15065522
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastric acid and salivary bicarbonate. Is there a relationship in duodenal ulcer patients?
    Namiot Z; Stasiewicz J; Markowski AR; Namiot DB; Jaroszewicz W; Kemona A; Górski J
    Rocz Akad Med Bialymst; 2004; 49():75-9. PubMed ID: 15631318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole is more effective than famotidine for preventing acute gastritis in rats.
    Topaloglu U; Muftuoglu T; Akturk Z; Ekinci H; Peker O; Unalmiser S
    Surg Today; 2004; 34(8):690-4. PubMed ID: 15290400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
    Omari TI; Haslam RR; Lundborg P; Davidson GP
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric ulcer despite no acid in a renal allograft recipient: what is the link?
    Canbakan B; Mizrak D; Keven K; Kaygusuz G; Kutlay S; Sengul S; Erbay B
    Nephrol Dial Transplant; 2005 Oct; 20(10):2279-81. PubMed ID: 16115851
    [No Abstract]   [Full Text] [Related]  

  • 6. Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?
    Madsen LG; Wallin L; Bytzer P
    Aliment Pharmacol Ther; 2004 Aug; 20(4):423-30. PubMed ID: 15298636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Grounds and perspectives of using geviskon--novel in Russia alginate-containing drug--in treatment of acid-dependent diseases of the digestive system].
    Tkachenko EI; Uspenskiĭ IuP
    Eksp Klin Gastroenterol; 2007; (4):41-6. PubMed ID: 18409489
    [No Abstract]   [Full Text] [Related]  

  • 8. Nocturnal acid breakthrough in subjects taking PPI b.i.d.
    Savarino V; Mela GS; Vigneri S
    Am J Gastroenterol; 1999 Feb; 94(2):536-7. PubMed ID: 10022667
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlling acid secretion: individual variation in response.
    Walt RP
    Br J Clin Pract Suppl; 1994; 75():9-12; discussion 13. PubMed ID: 8060804
    [No Abstract]   [Full Text] [Related]  

  • 10. Acid related disorders: a decade after the introduction of H2- receptor antagonists. Proceedings of an international symposium. Amsterdam, The Netherlands, 15 and 16 April 1988.
    Scand J Gastroenterol Suppl; 1988; 146():1-232. PubMed ID: 2906454
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.
    Javsicas LH; Sanchez LC
    Equine Vet J; 2008 Jan; 40(1):41-4. PubMed ID: 18083658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.
    Bergman MP; Klinkenberg-Knol EC; Faller G; Aar A; Lakhai W; Vandenbroucke-Grauls CM; Kuipers EJ; Appelmelk BJ
    Aliment Pharmacol Ther; 2005 Apr; 21(8):977-83. PubMed ID: 15813833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the antiulcerogenic activity of Maytenus robusta (Celastraceae) in different experimental ulcer models.
    de Andrade SF; Lemos M; Comunello E; Noldin VF; Filho VC; Niero R
    J Ethnopharmacol; 2007 Sep; 113(2):252-7. PubMed ID: 17629427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacoeconomic aspects of the use of proton pump inhibitors].
    Lazebnik LB; Masharova AA; Guseĭnzade MG
    Eksp Klin Gastroenterol; 2006; (4):67-72. PubMed ID: 17269427
    [No Abstract]   [Full Text] [Related]  

  • 15. [The possibilities of using gastrotsepin in treating digestive organ diseases].
    Kalinin AV; Loginov AF; Antokhin EA
    Voen Med Zh; 1993 Jun; (6):52-5. PubMed ID: 8367954
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of grandaxine in the treatment of patients with erosive-ulcerative stomach and gastroduodenal lesions].
    Vakhrushev IaM; Belova EV; Efremova LI
    Eksp Klin Gastroenterol; 2004; (4):21-4. PubMed ID: 15568662
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical value of the correction of disorders of intestinal microcenosis in patients with acid-dependent diseases of the digestive apparatus].
    Tkachenko EI; Uspenskiĭ IuP; Avalueva EB; Zakharchenko MM; Baryshnikova NV
    Eksp Klin Gastroenterol; 2004; (6):52-6. PubMed ID: 16259442
    [No Abstract]   [Full Text] [Related]  

  • 18. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
    Todd JA; Basu KK; de Caestecker JS
    Aliment Pharmacol Ther; 2005 Apr; 21(8):969-75. PubMed ID: 15813832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
    Isakov VA
    Eksp Klin Gastroenterol; 2004; (3):40-4. PubMed ID: 15560400
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial.
    Lundell L; Havu N; Miettinen P; Myrvold HE; Wallin L; Julkunen R; Levander K; Hatlebakk JG; Liedman B; Lamm M; Malm A; Walan A;
    Aliment Pharmacol Ther; 2006 Mar; 23(5):639-47. PubMed ID: 16480403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.